Millennium Management LLC 13D and 13G filings for ARS Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-07-14 5:47 pm Sale | 2026-06-30 | 13G | ARS PHARMACEUTICALS, INC SPRY | Millennium Management LLC | 2,520,937 2.500% | -3,395,093 (-57.39%) | Filing |
| 2026-03-31 6:43 pm Purchase | 2026-03-27 | 13G | ARS PHARMACEUTICALS, INC SPRY | Millennium Management LLC | 5,916,030 6.000% | 524,590 (+9.73%) | Filing |
| 2026-03-24 4:18 pm Purchase | 2026-03-17 | 13G | ARS PHARMACEUTICALS, INC SPRY | Millennium Management LLC | 5,391,440 5.400% | 5,391,440 (New Position) | Filing |